METACHRONOUS COLORECTAL LIVER METASTASIS
Authors:
- Cássio Virgílio Cavalcante de OliveiraCOCássio Virgílio Cavalcante de Oliveira
- Rodolfo Carvalho SantanaRSRodolfo Carvalho Santana
- Felipe José Fernandez CoimbraFCFelipe José Fernandez Coimbra
- Alfred KowAKAlfred Kow
- Timothy M. PawlikTPTimothy M. Pawlik
- Rene AdamRene Adam
- Olivier SoubraneOSOlivier Soubrane
- Paulo HermanPHPaulo Herman
- Ricardo Lemos Cotta-PereiraRCRicardo Lemos Cotta-Pereira
Open Access
- 1 January 2025
- journal article
- review article
- Published by FapUNIFESP (SciELO) in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
- Vol. 38, e1874
Abstract
Deaths related to colorectal cancer are generally associated with its metastases that affect the liver (50%) through the hematogenous route. Approximately 20-25% of these patients already have synchronous metastases in the liver at the time of primary tumor diagnosis. In others, liver metastases will occur during the course of the disease and are called metachronous. Metachronous metastases are believed to have a better prognosis; however, 20-25% of metastatic cases can be resected during the course of the disease. There is a lack of consensus on the diagnostic time interval for metastases to be considered metachronous in the consulted literature. Surgical treatment of metastases and lymph nodes is indicated, and extrahepatic neoplastic disease must be carefully evaluated. Liver transplantation can benefit the patient, should be evaluated, and is indicated in some special situations.Keywords
This publication has 22 references indexed in Scilit:
- Treatment of metachronous colorectal cancer metastases in the Netherlands: A population-based studyEuropean Journal of Surgical Oncology, 2022
- Selection criteria related to long-term survival following liver transplantation for colorectal liver metastasisAmerican Journal of Transplantation, 2019
- Response to preoperative chemotherapy: impact of change in total burden score and mutational tumor status on prognosis of patients undergoing resection for colorectal liver metastasesHPB, 2019
- Tumor Biology Rather Than Surgical Technique Dictates Prognosis in Colorectal Cancer Liver MetastasesJournal of Gastrointestinal Surgery, 2016
- Management of patients with colorectal liver metastasis in eleven questions and answersExpert Review of Anticancer Therapy, 2016
- Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trialAnnals of Oncology, 2014
- Should Patients With Peritoneal Carcinomatosis of Colorectal Origin With Synchronous Liver Metastases Be Treated With a Curative Intent? A Case-Control StudyAnnals of Surgery, 2013
- The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: A systematic reviewSurgery, 2012
- Epidemiology and Management of Liver Metastases From Colorectal CancerAnnals of Surgery, 2006
- Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal CancerAnnals of Surgery, 1999